Additionally, PKA activity is also found to be reduced in end-stage HF patients, whereas PKC hyperactivity is observed, which is a phenomenon that has been previously described [60,61], and may contribute to the contractile dysfunction observed in our patients. This evidence concerns the gene PRRT2 and hydrops fetalis.